80,99 €
Stem Cells: A Short Course is a comprehensive text for students delving into the rapidly evolving discipline of stem cell research. Comprised of eight chapters, the text addresses all of the major facets and disciplines related to stem cell biology and research. A brief history of stem cell research serves as an introduction, followed by coverage of stem cell fundamentals; chapters then explore embryonic and fetal amniotic stem cells, adult stem cells, nuclear reprogramming, and cancer stem cells. The book concludes with chapters on stem cell applications, including the role of stem cells in drug discovery and therapeutic applications in spinal cord injury, brain damage, neurological and autoimmune disorders, among others. Written by a leader in the field, Stem Cells: A Short Course appeals to both students and instructors alike, appealing to academic enthusiasm for stem cell research and applications.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 655
Veröffentlichungsjahr: 2015
Rob Burgess
Copyright © 2016 by John Wiley & Sons, Inc. All rights reserved.
Published by John Wiley & Sons, Inc., Hoboken, New Jersey. Published simultaneously in Canada.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission.
Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com.
Library of Congress Cataloging-in-Publication Data is available.
ISBN: 978-1-118-43919-7
To my wife, Jane, daughter, Zoie, son, Bobby, mother, Lola, and father, Bob
PREFACE TO THE PROFESSOR
PREFACE TO THE STUDENT
ACKNOWLEDGMENTS
LIST OF CASE STUDIES
LIST OF FOCUS BOXES
CHAPTER 1 A HISTORY OF STEM CELL RESEARCH
EARLY STUDIES
HEMATOPOIETIC STEM CELL DISCOVERY
MOUSE EMBRYONIC STEM CELL DISCOVERY
SUCCESSFUL NEURAL STEM CELL CULTURE
THE DISCOVERY OF CANCER STEM CELLS
HUMAN EMBRYONIC STEM CELL DISCOVERY
STEM CELLS AND CLONING
CORD BLOOD EMBRYONIC-LIKE STEM CELLS—AN ALTERNATIVE TO ES AND ADULT STEM CELLS
BREAKTHROUGH IN SPINAL CORD INJURY REPAIR
THE GENERATION OF IPS CELLS
THE DISCOVERY OF HUMAN AMNIOTIC STEM CELLS
HUMAN EMBRYONIC STEM CELLS GENERATED WITHOUT EMBRYO DESTRUCTION
HUMAN CLONING
MESENCHYMAL STEM CELL-DERIVED HUMAN KNEE CARTILAGE
THE FIRST CLINICAL TRIAL USING HUMAN EMBRYONIC STEM CELLS
MITOCHONDRIAL DNA: A BARRIER TO AUTOLOGOUS CELL THERAPEUTICS
INDUCED PLURIPOTENCY AND THE POTENTIAL TO SAVE ENDANGERED SPECIES
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 2 FUNDAMENTALS OF STEM CELLS
BASIC
IN VITRO
CELL CULTURE—A HISTORICAL PERSPECTIVE
STEM CELL CULTURE—OPTIMAL CONDITIONS AND TECHNIQUES
THE STUDY OF EMBRYONIC DEVELOPMENT
BASIC PROPERTIES OF STEM CELLS
TYPES OF STEM CELLS
THE POTENTIAL OF STEM CELLS IN MEDICINE AND MEDICAL RESEARCH
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 3 EMBRYONIC STEM, FETAL, AND AMNIOTIC STEM CELLS
ES CELLS
EC CELLS
EMBRYONAL GERM CELLS
COMPARING EMBRYONICALLY DERIVED CELLS
FETAL STEM CELLS
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READING
CHAPTER 4 ADULT STEM CELLS
DISCOVERY AND ORIGIN OF ASCs
BASIC PROPERTIES OF ASCs
EXAMPLES OF ASCs
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 5 NUCLEAR REPROGRAMMING
EXAMPLES OF NUCLEAR REPROGRAMMING IN NATURE
CELL FUSION
SOMATIC CELL NUCLEAR TRANSFER
INDUCED PLURIPOTENCY
ADVANTAGES OF IPS CELLS OVER OTHER CELL TYPES
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 6 CANCER STEM CELLS
BACKGROUND ON THE ORIGINS OF CANCER
DISCOVERY AND ORIGIN OF CANCER STEM CELLS
BASIC PROPERTIES OF CANCER STEM CELLS
SIGNALING PATHWAYS INVOLVED IN CANCER STEM CELL TRANSFORMATION
EXAMPLES OF CANCER STEM CELLS
STRATEGIES FOR TREATMENT TARGETING CANCER STEM CELLS
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 7 STEM CELLS AS DRUG DISCOVERY PLATFORMS
EMBRYONIC STEM CELLS AND MOUSE MODELS OF GENE FUNCTION
STEM CELL-BASED SCREENING ASSAYS
ANALYSIS OF DISEASE PATHWAYS
STEM CELLS AS A TOXICITY-TESTING PLATFORM
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
CHAPTER 8 THERAPEUTIC APPLICATIONS OF STEM CELLS
HISTORY OF STEM CELLS AS THERAPEUTICS
DISEASE-SPECIFIC TREATMENT AND PATIENT TRIALS
VETERINARY APPLICATIONS
STEM CELLS AS AN EMERGING INDUSTRY
CHAPTER SUMMARY
KEY TERMS
REVIEW QUESTIONS
THOUGHT QUESTION
SUGGESTED READINGS
ABOUT THE AUTHOR
INDEX
EULA
Chapter 1
Table 1.1
Chapter 2
Table 2.1
Chapter 3
Table 3.1
Table 3.2
Table 3.3
Chapter 4
Table 4.1
Table 4.2
Table 4.3
Table 4.4
Table 4.5
Chapter 5
Table 5.1
Table 5.2
Table 5.3
Chapter 6
Table 6.1
Chapter 7
Table 7.1
Chapter 8
Table 8.1
Table 8.2
Chapter 1
Figure 1.1
Timeline of historical advances in stem cell theory and research. (Adapted from Rob Burgess,
Stem Cells Handbook
(Humana Press), 2nd Edition, Chapter 1.)
Figure 1.2
The late Ernest McCulloch and James Till after accepting the 2005 Lasker Award for their studies on bone marrow-derived stem cells.
Ernest McCulloch is at left. (Photograph courtesy Environmental Protection Agency; reprinted with permission.)
Figure 1.3
Discovery of active neurogenesis in the adult brain. The arrows denote
3
H-thymidine uptake in glial cells in rodent brain regions associated with trauma. Neurons and neuroblasts also demonstrated some staining, confirming mitosis and corresponding neurogenesis. (Photo courtesy
Nature
(Altman and Das, 1967); reprinted with permission.)
Figure 1.4
Dr. Robert Alan Goodwith, President Richard Nixon, and colleagues at the White House Conquest of Cancer Program in 1973
. Dr. Goodwith is circled; President Nixon is second from the left. Also pictured is Dr. Robert L. Clark of the University of Texas M.D. Anderson Cancer Center. (Photo courtesy Nixon archives; reprinted with permission.)
Figure 1.5
Hematopoietic stem cells isolated from human umbilical cord blood. (a) Colony cultured on methylcellulose. (b) Myelocytes and metamyelocytes. (c) Neutrophils. (d) Dividing myelocyte. (Photo courtesy Dr. G. Prindull and
Acta Paediatrica Scandinavica
(Prindull and Prindull, 1978); reprinted with permission.)
Figure 1.6
The discovery of mouse embryonic stem cells. (Left) The first published photo documentation of a mouse embryonic stem cell colony. (Right) Embryoid bodies demonstrating a variety of different cell types including (a) giant cells, (b) neuron-like cells, (c) endodermal cells, (d) cartilage, and (e) cells forming tubules. Source: Martin, 1981. Reproduced with permission from G. R. Martin.)
Figure 1.7
Generation and characterization of multipotent neural stem cells. (a) Non-cultured control and (b) 8-day coculture of transformed neural stem cells (stained in blue) with dissociated primary mouse cerebellum demonstrating process formation. (c–e) Sections of the cerebellar region of a mouse brain transplanted with LacZ tagged v-myc transformed neural stem cells. (c) Six hours post transplant; (d and e) 72 hours post transplant demonstrating proper migration into the molecular layer. (Photos courtesy Constance Cepko and
Cell
(Snyder et al., 1992); reprinted with permission.)
Figure 1.8
Differentiation capacity of SL-IC cancer stem cells. (a and c) Unsorted and (b and d)
sorted CD34+/CD38- SL-ICs demonstrating colonization of the bone marrow of a recipient NOD/SCID mouse as assayed by the presence of the marker CD45 which is a transmembrane glycoprotein present on the cell surface of all cells of hematopoietic origin. (Photos courtesy John Dick and
Nature Medicine
(Bonnet and Dick, 1997); reprinted with permission.)
Figure 1.9
Derivation of the 1st clonal human embryonic stem cell line. (a) First inner cell mass colony cultured on a mouse feeder layer. (b) H9 clonal undifferentiated human ES cell colony. (c) High magnification of individual human ES cells. (d) Differentiated human ES cells cultured in the absence of a mouse feeder layer. (Photos courtesy Dr. James A. Thomson and
Science
(Thomson et al., 1998); reprinted with permission.)
Figure 1.10
Diagrammatic illustration of Somatic Cell Nuclear Transfer (SCNT). See text for a detailed description. (Diagram courtesy Wikipedia.org; reprinted with permission.)
Figure 1.11
Diagram of the procedure undertaken for cloning Dolly the sheep. (Diagram courtesy Wikimedia Commons; reprinted with permission.)
Figure 1.12
Advanced Cell Technology’s parthenogenetically activated human embryos. (a)
Isolated
unfertilized eggs. (b) 4–6 cell embryos 48 hours after activation of parthenogenesis. (c) Day 6 revealing blastocoele cavities indicated by arrows. (Photos courtesy Jose B. Cibelli and
Scientific American
(Cibelli et al., 2002); reprinted with permission.)
Figure 1.13
Somatic cell nuclear transfer cumulus cell-derived human embryos. (a)
12 hou
rs, (b) 36 hours (2 cell stage), (c) 72 hours (4-cell stage), and (d) 72 hours (6-cell stage) after nuclear transfer. (c) and (d) indicate nuclei stained with the fluorescent label bisbenzimide. (Photos courtesy Jose B. Cibelli and
Scientific American
(Cibelli et al., 2002); reprinted with permission.)
Figure 1.14
Marker characterization of cord blood embryonic-like stem cells. Cells were positive for the classical ES markers SSEA-3, SSEA-4, Tra 1-60, Tra 1-81 and Oct-4 yet, as is characteristic of embryonic stem cells, the CBEs did not express SSEA-1. (Photos courtesy Colin P. McGuckin and (McGuckin et al., 2005); reprinted with permission.)
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
